Armed With New Data, Pfizer To Seek Full Approval Of Vaccine For Adolescents

By Kelly Lienhard / November 22, 2021 at 1:04 PM
Armed with new longer-term data showing their COVID-19 vaccine is 100% effective in adolescents, Pfizer and BioNTech plan to ask FDA to fully approve the vaccine for that age group, the companies said Monday (Nov. 22) . The vaccine currently is fully approved for individuals 16 and older and is only available for patients ages 12 to 15 under emergency use authorization. The companies "measured seven days through over four months after the second dose" and found that all 30...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.